IP Library › Assignment 027641/0093
Patent Assignment
Reel/Frame 027641/0093

Assignment of Assignor's Interest

Recorded: 2012-02-02 Pages: 6
Assignor
Assignee
VALEANT INTERNATIONAL (BARBADOS) SRL
WELCHES, CHRIST CHURCH, BB17154, BARBADOS
Covered Properties (5)
Methods and Compositions for the Prevention and Treatment of Diabetes Mellitus
Patent: 5,871,769 →
Application: 08/844,908 →
Methods and Compositions for the Prevention and Treatment of Immunological Disorders, Inflammatory Diseases and Infections
Patent: 5,939,394 →
Application: 08/844,909 →
Methods and Compositions for the Prevention and Treatment of Muscle Cramps and Improving Muscular Strength Utilizing an Effective Amount of Magnesium Gluconate
Patent: 5,922,765 →
Application: 08/844,988 →
Treating Eczema with a Combination of Isotonic Saline Ocean and Nasal Mast Cell Stabilizers
Patent: 6,596,284 →
Application: 10/063,493 →
Rapidly Dissolving Vitamin Formulation and Methods of Using the Same
Application: 12/638,629 →
Publication: US 2010/0190739
Related Assignments (23)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Apr 23, 1997
From: FLEMING, THOMAS E.; MANSMANN, HERBERT C. JR.
To: FLEMING & COMPANY, PHARMACEUTICALS
Reel/Frame 008529/0356 →
Assignment of Assignor's Interest Apr 23, 1997
From: FLEMING, THOMAS E.; MANSMANN, HERBERT C., JR.
To: FLEMING & COMPANY, PHARMACEUTICALS
Reel/Frame 008516/0124 →
Assignment of Assignor's Interest Apr 23, 1997
From: FLEMING, THOMAS E.; MANSMANN, HERBERT C., JR.
To: FLEMING & COMPANY, PHARMACEUTICALS
Reel/Frame 008516/0103 →
Assignment of Assignor's Interest Apr 30, 2002
From: FLEMING, THOMAS E.; HELLER, THEODORE H
To: FLEMING & COMPANY
Reel/Frame 012636/0729 →
Corrective Assignment to Correct the 2ND Assignor's Name. Document Previously Recorded on Reel 012636 Frame 0729 Asignor Hereby Confirms the Assignment of the Entire Interest. Oct 15, 2002
From: FLEMING, THOMAS E.; FELLER, THEODORE H
To: FLEMING & COMPANY
Reel/Frame 013399/0802 →
Assignment of Assignor's Interest May 6, 2003
From: FLEMING, THOMAS E.; FLEMING & COMPANY PHARMACEUTICALS
To: MAGONATE SPORT LLC
Reel/Frame 014027/0388 →
Assignment of Assignor's Interest Jun 9, 2003
From: FLEMING & COMPANY PHARMACEUTICALS
To: MAGONATE SPORT LLC
Reel/Frame 014137/0854 →
Assignment of Assignor's Interest Apr 8, 2010
From: SUTTERER, ANGELA; YACHECHAK, SUZANNE M.
To: FLEMING AND COMPANY, PHARMACEUTICALS
Reel/Frame 024204/0969 →
Corporate Dissolution Feb 2, 2012
From: MAGONATE SPORT, LLC
To: MAGONATE SPORT, LLC
Reel/Frame 027641/0511 →
Court Order & Settlement Agreement Feb 2, 2012
From: MAGONATE SPORT LLC
To: FLEMING AND COMPANY, PHARMACEUTICALS
Reel/Frame 027641/0587 →
Security Agreement Jul 30, 2012
From: VALEANT INTERNATIONAL BERMUDA (FORMERLY KNOWN AS VALEANT INTERNATIONAL (BARBADOS) SRL); VALEANT LABORATORIES INTERNATIONAL BERMUDA (FORMERLY KNOWN AS BIOVAIL LABORATORIES INTERNATIONAL (BARBADOS) SRL)
To: GOLDMAN SACHS LENDING PARTNERS LLC
Reel/Frame 028680/0866 →
Change in Name and Country of Incorporation Aug 9, 2012
From: VALEANT INTERNATIONAL (BARBADOS) SRL
To: VALEANT INTERNATIONAL BERMUDA
Reel/Frame 028757/0052 →
Assignment of Assignor's Interest Mar 26, 2013
From: VALEANT INTERNATIONAL BERMUDA
To: VALEANT PHARMACEUTICALS LUXEMBOURG S.A.R.L.
Reel/Frame 030087/0301 →
Notice of Succession of Agency Jan 9, 2015
From: GOLDMAN SACHS LENDING PARTNERS, LLC
To: BARCLAYS BANK PLC, AS SUCCESSOR AGENT
Reel/Frame 034749/0689 →
Security Interest Jul 19, 2017
From: VALEANT PHARMACEUTICALS LUXEMBOURG S.A.R.L.
To: THE BANK OF NEW YORK MELLON
Reel/Frame 043046/0217 →
Security Interest Feb 26, 2018
From: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 045444/0299 →
Security Interest Feb 26, 2018
From: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC
To: THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT
Reel/Frame 045444/0634 →
Intellectual Property Security Agreement Jul 3, 2019
From: BAUSCH HEALTH IRELAND LIMITED; BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH, CANADA INC.; TECHNOLAS PERFECT VISION GMBH
To: THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT
Reel/Frame 049672/0652 →
Assignment of Assignor's Interest Oct 24, 2019
From: VALEANT PHARMACEUTICALS LUXEMBOURG S.A.R.L.
To: BAUSCH HEALTH IRELAND LIMITED
Reel/Frame 051803/0911 →
Security Interest Oct 5, 2021
From: BAUSCH & LOMB IRELAND LIMITED; BAUSCH HEALTH COMPANIES INC.; DR. GERHARD MANN CHEM.-PHARM. FABRIK GMBH; TECHNOLAS PERFECT VISION GMBH
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 057821/0800 →
Release of Security Interest Apr 8, 2025
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: SOLTA MEDICAL, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED); SALIX PHARMACEUTICALS, INC.
Reel/Frame 070778/0199 →
Release of Security Interest Nov 20, 2025
From: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
To: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC
Reel/Frame 073637/0001 →
Release of Security Interest Nov 20, 2025
From: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
To: BAUSCH HEALTH IRELAND LIMITED; BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH, CANADA INC.; TECHNOLAS PERFECT VISION GMBH
Reel/Frame 073637/0222 →